Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Haemopoietic Growth Factors

Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

Bone Marrow Transplantation volume 27, pages 499–505 (2001)Cite this article

Abstract

We studied the effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on hematopoietic recovery and clinical outcome in patients undergoing allogeneic peripheral blood stem cell (PBSC) transplantation. Fifty-six patients with hematological malignancies who underwent allogeneic PBSC transplantation between 1995 and 1998 were entered into this study. Twenty-eight patients who received daily G-CSF from day +1 after allogeneic PBSC transplantation until the absolute neutrophil count (ANC) reached >0.5 × 109/l for 3 consecutive days were compared with 28 patients (control group) who did not receive G-CSF in a non-randomized manner. The study group and the control group were comparable with respect to baseline patient and transplantation characteristics. Median times to ANC of >0.5 × 109/l and 1 × 109/l with or without G-CSF were 12 days (range 8–21), 13 days (10–32) (P = 0.04) and 13 days (9–21), 15 days (11–44) (P = 0.02), respectively. Median times to reach a platelet count of >20 × 109/l with and without G-CSF were 11 days (0–20) and 13 days (9–26), respectively (P = 0.03). The incidence of febrile episodes was significantly lower with G-CSF, 75% vs 100% (P = 0.008). Patients receiving G-CSF had less grade III–IV mucositis than those who did not receive G-CSF (P = 0.01). There was also no increase in the incidence and severity of acute GVHD in patients using G-CSF (P = 0.22). Although the number of relapsing patients was greater in the G-CSF group (seven vs three patients), this was not statistically significant (P = 0.24). Disease-free and overall survival rates did not differ between the two groups (P = 0.58 and 0.53, respectively). The administration of G-CSF after allogeneic PBSC transplantation provided faster neutrophil and platelet engraftment associated with less severe mucositis and less febrile episodes. Bone Marrow Transplantation (2001) 27, 499–505.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Masaoka T, Takaku F, Kato S et al. Recombinant human granulocyte–macrophage colony-stimulating factor in allogeneic bone marrow transplantation Exp Hematol 1985 17: 1047–1450

    Google Scholar 

  2. Linch D, Scarffe H, Proctor S et al. Randomised vehicle controlled dose finding study of glycosylated recombinant human granulocyte-colony stimulating factor after bone marrow transplantation Bone Marrow Transplant 1993 11: 307–310

    CAS  PubMed  Google Scholar 

  3. Nemunaitis J, Buckner CD, Appelbaum FR et al. Phase I/II trial of recombinant granulocyte–macrophage colony stimulating factor following allogeneic bone marrow transplantation Blood 1991 77: 2065–2071

    CAS  PubMed  Google Scholar 

  4. Powles R, Smith C, Milan S et al. Human recombinant GM-CSF in allogeneic bone marrow transplant for leukemia: double blind placebo controlled trial Lancet 1990 336: 1417–1420

    Article  CAS  PubMed  Google Scholar 

  5. DeWitte T, Gratwohl A, Van Der LN et al. Recombinant human granulocyte-colony stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation Blood 1992 79: 1359–1365

    CAS  Google Scholar 

  6. Nemunaitis J, Rosenfeld C, Ash R et al. Phase III double blind trial of rhGM-CSF following bone marrow transplant Blood 1993 82: 1128a

    Google Scholar 

  7. Schriber RJ, Chao NJ, Long GD et al. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation Blood 1994 84: 1680–1684

    CAS  PubMed  Google Scholar 

  8. Linch JD, Milligan DW, Winfield DA et al. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomised BNLI trial Br J Haematol 1997 99: 933–938

    Article  CAS  PubMed  Google Scholar 

  9. Dunlop DJ, Fitasimons EJ, McMurray A et al. Filgrastim fails to improve hematopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue Br J Cancer 1994 70: 943–945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Spitzer G, Adkins DR, Spencer V et al. Randomized study of growth factors post-peripheral-stem-cell transplant: neutrophil recovery is improved with modest clinical benefit J Clin Oncol 1994 12: 661–670

    Article  CAS  PubMed  Google Scholar 

  11. Schimazaki C, Oku N, Uchiyama H et al. Hematopoietic recovery after peripheral blood progenitor cell transplantation Bone Marrow Transplant 1994 13: 271–275

    Google Scholar 

  12. Gratwohl A, Passweg J, Baldomero H, Hermans J . Blood and bone marrow transplantation activity in Europe Bone Marrow Transplant 1998 22: 227–240

    Article  CAS  PubMed  Google Scholar 

  13. Majolino I, Saglino G, Scime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation Bone Marrow Transplant 1996 17: 555–560

    CAS  PubMed  Google Scholar 

  14. Üstün C, Arslan Ö, Beksac M et al. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft versus host disease and relapse Biol Blood Marrow Transplant 1999 5: 28–35

    Article  PubMed  Google Scholar 

  15. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts Blood 1995 85: 1659–1665

    PubMed  Google Scholar 

  16. Körbling M, Fliedner TM . The evaluation of clinical peripheral blood stem cell transplantation Bone Marrow Transplant 1996 17: (Suppl. 2) 4–11

    Google Scholar 

  17. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplantation for hematologic malignancy: preliminary comparison of outcome with bone marrow transplantation Bone Marrow Transplant 1996 17: 703–708

    CAS  PubMed  Google Scholar 

  18. Rosenfeld C, Collins R, Pineiro L et al. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study J Clin Oncol 1996 4: 1314–1319

    Article  Google Scholar 

  19. Pavletic ZS, Michael R, Bishop R et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies J Clin Oncol 1997 15: 1608–1616

    Article  CAS  PubMed  Google Scholar 

  20. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794–2800

    CAS  PubMed  Google Scholar 

  21. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825–828

    CAS  PubMed  Google Scholar 

  22. Nemunaitis J, Anasetti C, Storb R et al. Phase I/II trial of recombinant human granulocyte–macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors Blood 1992 79: 2572–2577

    CAS  PubMed  Google Scholar 

  23. Przepiorka D, Smith T, Folloder J et al. A controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation Blood 1998 92: (Suppl. 1) 523a

    Google Scholar 

  24. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. for Spanish Group of Allogeneic PBSC Transplantation High incidence of chronic graft versus host disease (GVHD) after allogeneic blood progenitor cell transplantation (allo-PBSCT) from matched related donors Blood 1996 88: (Suppl. 1) 2455a

    Google Scholar 

  25. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 454–464

    Google Scholar 

  26. Karthaus M, Rosenthal C, Ganser A . Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies? Bone Marrow Transplant 1999 24: 1095–1108

    Article  CAS  PubMed  Google Scholar 

  27. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells J Clin Oncol 1995 13: 2547–2555

    Article  CAS  PubMed  Google Scholar 

  28. Berger C, Bertz H, Schmoor C et al. Influence of recombinant human granulocyte colony-stimulating factor (filgastrim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors Bone Marrow Transplant 1999 23: 983–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation Lancet 1994 343: 696–700

    Article  CAS  PubMed  Google Scholar 

  30. Martin-Algarra S, Bishop MR, Tarantolo S et al. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Exp Hematol 1995 23: 1503–1508

    CAS  PubMed  Google Scholar 

  31. Nemunaitis J, Rosenfeld CS, Ash R et al. Phase III randomized, double-blind placebo-controlled rhGM-CSF following allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 949–954

    CAS  PubMed  Google Scholar 

  32. Gordon B, Spadinger A, Hodges E et al. Effect of granulocyte–macrophage colony stimulating factor on oral mucositis after hematopoietic stem cell transplantation J Clin Oncol 1994 12: 1917–1922

    Article  CAS  PubMed  Google Scholar 

  33. Azevedo WM, Aranha FJP, Gouvea JV et al. Allogeneic transplantation with blood stem cells mobilized by G-CSF for hematologic malignancies Bone Marrow Transplant 1995 16: 647–653

    CAS  PubMed  Google Scholar 

  34. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF) Blood 1995 85: 1666–1672

    CAS  PubMed  Google Scholar 

  35. Hagglund H, Ringden O, Remberger M et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donor, compared to bone marrow Bone Marrow Transplant 1998 22: 131–136

    Article  CAS  PubMed  Google Scholar 

  36. Pan L, Delmonte J, Jalonen C, Ferrara J . Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes T-lymphocytes towards type 2 cytokine production and reduced severity of experimental graft-versus-host disease Blood 1995 86: 4422–4429

    CAS  PubMed  Google Scholar 

  37. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus host disease Blood 1997 90: 4705–4709

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Ankara University School of Medicine, Ankara, Turkey

    M Özcan, C Üstün, E Akçağlayan, H Akan, Ö Arslan, O İlhan, M Beksaç, G Gürman, T Demirer, M Arat, H Çelebi, N Konuk, A Uysal & H Koç

Authors
  1. M Özcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Üstün
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Akçağlayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Akan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ö Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O İlhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Beksaç
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Gürman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Demirer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Arat
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H Çelebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. N Konuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A Uysal
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. H Koç
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özcan, M., Üstün, C., Akçağlayan, E. et al. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 27, 499–505 (2001). https://doi.org/10.1038/sj.bmt.1702816

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702816

Keywords

This article is cited by

Search

Advanced search

Quick links